Introduction
Head spasms are third-generation antibiotics with the advantages of a broad spectrum of antibacterial, antibacterial activity, long half-lifes and good tissue penetration, and are widely used in primary health-care facilities for the treatment of grenacin and positive infections. Unreasonable use, however, not only affects the effects of treatment, but may also lead to the creation of drug-resistant bacteria and an increase in adverse reactions. Therefore, the proper use of twilight is essential.
II. Anti-bacterial spectrometry and mechanisms of action of twilight
Head spasms have a strong anti-bacterial activity for gerranium cactus, pneumocococcus, fungi, influenza haemophilus influenzae, etc., and can inhibit the synthesis of bacterial cell walls, thus contributing to microbicide. There is also some anti-bacterial effect in the case of gland positives, such as pneumocococcus, but relatively weak activity compared to the specific antibiotics for gland positives.
Adaptation certificates
(i) Respiratory infections
In the case of community access to pneumonia, especially caused by streptococcus, influenza haemophilus influenzae and so forth, head spasms can be used alone when the disease is light and without a drug-resistant risk factor; in the case of hospital access to pneumonia, other drugs can be used in combination with head spasms if the possible presence of gland cactus infection is considered. In addition, respiratory infections, such as acute bronchitis, chronic bronchitis, are optional when the fungi is sensitive.
(ii) Utility infection
Common urinary system infections, such as bladderitis and kidney diarrhea, often give rise to convulsions as effective therapeutic drugs in cases where the fungus is glandella, such as coli-Eshicella. In reproductive system infections, such as pelvic and gonorrhoea urea, head spines also have an important application value for the effective removal of pathogens such as gonorrhea.
(iii) Skin soft tissue infections
In the case of shallow skin soft tissue infections such as gills, gills and beeweeds, head spines can be used for anti-infection treatment when the infection is suspected to be a combination of glazine fungus (sensitized twig) or glancella. Infections of deep soft tissues, such as Dan poisoning, may also be selected on the basis of the condition.
(iv) Cervical infections
In the case of abdominal infectious diseases such as acute cholesterolitis and appendicitis, head spasm can be used in conjunction with anti-aerobic drugs such as mitraz for the treatment of possible co-infection with anaerobic bacteria, effective control of inflammation and prevention of spread.
(v) Central nervous system infections
For meningitis, especially caused by haemophilus influenzae, pneumocococcus, the hysteria can achieve effective microbicide concentrations in cerebral fluids through a blood-brain barrier, which can be one of the important therapeutic drugs, but usually require large doses of use and a combination of other drugs depending on the condition.
IV. Usage
(i) Adult
General infections, 1-2 times per day, 1-2 g per time, muscle injection or intravenous drip. For serious infections, such as sepsis, meningitis, etc., the dose can be increased to 4 g/day, with 2-3 doses. In the case of intravenous dripping, the drug may be dissolved in the physico-saline water or 5% glucose solution at concentrations generally not exceeding 1% and for a period of not less than 30 minutes to reduce intravenous irritation.
(ii) Children
Daily dosages of 20 – 80 mg/kg at 1-2 times. In the case of newborns, especially premature babies, the dose should be adjusted to take into account, inter alia, liver and kidney function and body weight, generally not exceeding 50 mg/kg per day during the first week of life, with two doses to avoid adverse effects from drug accumulation.
V. Adverse effects and treatment
(i) Gastrointestinal reaction
More common, such as nausea, vomiting, diarrhoea. When symptoms are generally light, they can be mitigated by diet adjustment, e.g., light, easy to digest, and small amounts of meals. In case of serious diarrhoea, the possibility of pseudo-film intestinal inflammation should be observed, the medication must be stopped in a timely manner and excreta checked and, if necessary, treated with drugs such as mitazine or vancomicin.
(ii) Allergies
In the form of rashes, itchings, fevers, etc., allergies can occur. Lighter sensitization can provide treatment such as chloralate for anti-hotamine drugs and closely observe changes in the condition. In case of an allergy shock, there should be an immediate stop, an in-situ rescue, the maintenance of an open respiratory tract, the provision of medicines such as adrenaline, sugary cortex hormones, and support for the treatment of oxygen and rehydration.
(iii) Blood system anomalies
White cells can be reduced, slabs reduced, etc. Blood routines are regularly reviewed, and if the white cell or slab is slightly reduced, it can be closely observed and normality can be gradually restored after general cuts. If the reduction is significant, the medication should be stopped in a timely manner and drug treatment, such as a particle-cell concentration irritation factor, should be given to leukemia cells or slabs, depending on the circumstances, and other factors that cause abnormalities in the blood system should be checked.
(iv) Damage to liver and kidney function
In a small number of cases, hepato-renal function indicators, such as increased aminosterase, increased chlamydia and increased haematoma, may be abnormal. The liver and kidney function should be monitored regularly during the use of the drug and, if it is slightly elevated, it may be continued with close monitoring or appropriate dose adjustments; if the increase is significant, the drug should be discontinued and appropriate treatments such as liver protection, kidney care, such as the use of reductive cythopaedic glycerine for liver protection, improved kidney injection, etc.
VI. NOTES
(i) Interrogation of allergies
Before the use of head spasms, patients must be asked in detail about their history of drug allergies, especially for beta-neamide antibiotics, such as headgills and penicillin, which should be carefully used or banned. In the case of allergies, the use should also be made more visible and alert to allergies.
(ii) Drug interaction
Co-use with calcium-containing solutions or with drugs is avoided, as corrosive pines and calcium ions can form insoluble sediments, which can lead to the formation of cholesterols, kidneys, etc., which can cause acute kidney failure in serious cases. If calcium is required, the head splint should be used at least 48 hours apart. At the same time, when used in combination with amino-cyanide antibiotics, renal toxicity may increase and should be carefully combined and closely monitored.
(iii) Drugs for special population groups
Pregnant and lactating women should be careful and should use it only after a clear indication has been made and the advantages and disadvantages have been weighed, and breastfeeding should be suspended for the duration of its use. In the case of elderly patients, due to a reduction in liver and kidney function, the dose should be appropriately adjusted to their liver and kidney function and the monitoring of adverse effects should be strengthened.
(iv) Choice of the method of delivery
Injection of muscles should be carried out in the deep in order to alleviate local pain and constriction. In the case of intravenous drops, the speed of drops and drug concentrations are strictly controlled to avoid adverse reactions such as diarrhea due to over-drives or excessive concentrations.
(v) Reasonability of treatment
Reasonable treatment should be determined on the basis of factors such as the location of the infection, its severity and the type of pathogens. The general course of treatment for infections is 7 – 14 days, but for certain serious infections, such as osteoporosis and endometriosis, it may need to be extended for weeks or months. Avoiding the risk of re-emergence of infection as a result of premature detoxification, as well as extending the course of treatment to avoid increasing the risk of drug resistance and adverse reactions.
Concluding remarks
In the treatment of gelatin and positive infections, primary health-care institutions should strictly control the monitoring and treatment of adaptive certificates, usage, care and adverse effects, following the principle of rational use, improving the effectiveness of treatment, reducing the incidence of resistance and adverse effects, providing safe and effective anti-infection treatment for patients and safeguarding the health of the population at the grass-roots level. At the same time, the training of medical personnel should be strengthened, knowledge should be kept up to date, the level of rational use of medicines should be raised and the rational use of antibacterial drugs in primary health-care institutions should be promoted.
